Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term randomized, double-blind Phase 3 study of lemborexant in insomnia disorder
jRCT2080223414Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of lemborexant in Insomnia (3 arms), sponsored by Eisai Co., Ltd. Started Dec 2016; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2080223414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223414.